reserpine has been researched along with valinomycin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Christensen, SB; Holler, JG; Mølgaard, P; Olsen, CE; Slotved, HC | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Fishkes, H; Kanner, BI; Schuldiner, S | 1 |
| Njus, D; Radda, GK | 1 |
| Cidon, S; Gershon, MD; Nunez, EA; Tamir, H | 1 |
| Bendahan, A; Kanner, BI | 1 |
| Futai, M; Manabe, T; Moriyama, Y; Tashiro, Y; Yoshimori, T | 1 |
| Gerner, EW; Gillies, RJ; Xie, X | 1 |
| DiDiodato, G; Sharom, FJ | 1 |
| Chakrabarti, P; Choudhuri, BS; Sen, S | 1 |
| Permar, S; Sun, Z; Zhang, Y | 1 |
1 review(s) available for reserpine and valinomycin
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
16 other study(ies) available for reserpine and valinomycin
| Article | Year |
|---|---|
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans | 2003 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Chalcone; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Role of a transmembrane pH gradient in epinephrine transport by chromaffin granule membrane vesicles.
Topics: Animals; Biological Transport, Active; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cattle; Chromaffin Granules; Chromaffin System; Dicyclohexylcarbodiimide; Epinephrine; Hydrogen-Ion Concentration; In Vitro Techniques; Intracellular Membranes; Ionophores; Nigericin; Reserpine; Valinomycin | 1978 |
A potassium ion diffusion potential causes adrenaline uptake in chromaffin-granule 'ghosts'.
Topics: Animals; Cattle; Cell Membrane; Chromaffin Granules; Chromaffin System; Diffusion; Epinephrine; In Vitro Techniques; Membrane Potentials; Potassium; Reserpine; Spectrometry, Fluorescence; Valinomycin | 1979 |
ATP-dependent uptake of 5-hydroxytryptamine by secretory granules isolated from thyroid parafollicular cells.
Topics: Adenosine Triphosphate; Animals; Biological Transport, Active; Blotting, Western; Cytoplasmic Granules; Hydrogen-Ion Concentration; Immunoenzyme Techniques; In Vitro Techniques; Membrane Potentials; Potassium; Proton-Translocating ATPases; Reserpine; Serotonin; Sheep; Thyroid Gland; Valinomycin | 1991 |
Transport of 5-hydroxytryptamine in membrane vesicles from rat basophilic leukemia cells.
Topics: Adenosine Triphosphate; Animals; Basophils; Biological Transport; Cell Line; Dopamine; Epinephrine; Imipramine; Leukemia, Experimental; Nigericin; Norepinephrine; Rats; Reserpine; Serotonin; Sodium; Valinomycin | 1985 |
ATP-dependent uptake of anti-neoplastic agents by acidic organelles.
Topics: Adenosine Triphosphate; Ammonium Chloride; Animals; Antineoplastic Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cattle; Cells, Cultured; Chromaffin Granules; Daunorubicin; Drug Resistance; Hydrogen-Ion Concentration; Mice; Nigericin; Organelles; Proteolipids; Proton-Translocating ATPases; Quinidine; Reserpine; Valinomycin; Vanadates; Verapamil | 1994 |
Characterization of a diamine exporter in Chinese hamster ovary cells and identification of specific polyamine substrates.
Topics: Animals; Biological Transport; CHO Cells; Cricetinae; Hydrogen-Ion Concentration; Putrescine; Reserpine; Valinomycin; Verapamil | 1997 |
Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Membrane; Colchicine; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Leupeptins; Oligopeptides; Peptides; Reserpine; Valinomycin; Vinblastine | 1997 |
Isoniazid accumulation in Mycobacterium smegmatis is modulated by proton motive force-driven and ATP-dependent extrusion systems.
Topics: Adenosine Triphosphate; Antitubercular Agents; Biological Transport, Active; Calcium Channel Blockers; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Diltiazem; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Ionophores; Isoniazid; Mycobacterium smegmatis; Nifedipine; Nigericin; Proton-Motive Force; Reserpine; Uncoupling Agents; Valinomycin; Vanadates; Verapamil | 1999 |
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
Topics: Antitubercular Agents; Cell Survival; Colony Count, Microbial; Culture Media; Drug Interactions; Drug Resistance, Bacterial; Humans; Hydrogen-Ion Concentration; Ionophores; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reserpine; Serum Albumin, Bovine; Time Factors; Tuberculosis; Valinomycin | 2002 |